Patterns and predictors of colorectal cancer test use in the adult U.S. population
- PMID: 15139050
- DOI: 10.1002/cncr.20276
Patterns and predictors of colorectal cancer test use in the adult U.S. population
Abstract
Background: Screening is effective in reducing the incidence and mortality of colorectal cancer. Rates of colorectal cancer test use continue to be low.
Methods: The authors analyzed data from the National Health Interview Survey concerning the use of the home-administered fecal occult blood test (FOBT) and sigmoidoscopy/colonoscopy/proctoscopy to estimate current rates of colorectal cancer test use and to identify factors associated with the use or nonuse of tests.
Results: In 2000, 17.1% of respondents reported undergoing a home FOBT within the past year, 33.9% reported undergoing an endoscopy within the previous 10 years, and 42.5% reported undergoing either test within the recommended time intervals. The use of colorectal cancer tests varied by gender, race, ethnicity, age, education, income, health care coverage, and having a usual source of care. Having seen a physician within the past year had the strongest association with test use. Lack of awareness and lack of physician recommendation were the most commonly reported barriers to undergoing such tests.
Conclusions: Less than half of the U.S. population age >/= 50 years underwent colorectal cancer tests within the recommended time intervals. Educational initiatives for patients and providers regarding the importance of colorectal cancer screening, efforts to reduce disparities in test use, and ensuring that all persons have access to routine primary care may help increase screening rates.
Copyright 2004 American Cancer Society.
Similar articles
-
Colorectal cancer test use from the 2005 National Health Interview Survey.Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1623-30. doi: 10.1158/1055-9965.EPI-07-2838. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18628413
-
Predictors of colorectal cancer screening participation in the United States.Am J Gastroenterol. 2003 Sep;98(9):2082-91. doi: 10.1111/j.1572-0241.2003.07574.x. Am J Gastroenterol. 2003. PMID: 14499792
-
Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System.J Fam Pract. 2002 Sep;51(9):761-6. J Fam Pract. 2002. PMID: 12366896
-
Adherence with colorectal cancer screening guidelines: a review.Prev Med. 2004 May;38(5):536-50. doi: 10.1016/j.ypmed.2003.12.011. Prev Med. 2004. PMID: 15066356 Review.
-
[Test for occult blood in feces: a method for reducing the mortality from colorectal cancer?].Gastroenterol Clin Biol. 1996;20(3):225-7. Gastroenterol Clin Biol. 1996. PMID: 8763058 Review. French. No abstract available.
Cited by
-
Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA.Healthcare (Basel). 2021 May 12;9(5):569. doi: 10.3390/healthcare9050569. Healthcare (Basel). 2021. PMID: 34065816 Free PMC article.
-
New Mexico's capacity for increasing the prevalence of colorectal cancer screening with screening colonoscopies.Prev Chronic Dis. 2005 Jan;2(1):A07. Epub 2004 Dec 15. Prev Chronic Dis. 2005. PMID: 15670460 Free PMC article.
-
Psychosocial variables associated with colorectal cancer screening in South Australia.Int J Behav Med. 2011 Dec;18(4):302-9. doi: 10.1007/s12529-010-9101-1. Int J Behav Med. 2011. PMID: 20496170
-
Automated telephone calls improved completion of fecal occult blood testing.Med Care. 2010 Jul;48(7):604-10. doi: 10.1097/MLR.0b013e3181dbdce7. Med Care. 2010. PMID: 20508529 Free PMC article. Clinical Trial.
-
An evaluation of an Extension for Community Healthcare Outcomes (ECHO) intervention in cancer prevention and survivorship care.BMC Med Inform Decis Mak. 2022 May 17;22(1):135. doi: 10.1186/s12911-022-01874-x. BMC Med Inform Decis Mak. 2022. PMID: 35581580 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous